Leadership: Page 12
-
Podcast
Woman of the Week: 82VS’s Trier Bryant
Welcome to the Woman of the Week podcast, a weekly discussion that illuminates the unique stories of women leaders who are catalyzing change throughout the life sciences industry. You can check out all our podcast episodes here. Not every leader makes it their mission to go where the fire ...
By Taren Grom • Nov. 9, 2022 -
Podcast
Woman of the Week: City of Hope’s Gulden Mesara
Charged with bridging the 100-year-old research center to its future mission of holistic patient cancer care, Mesara is bringing decades of experience in communications and culture creation.
By Taren Grom • Nov. 2, 2022 -
Trendline
Commercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
Vaccine chief’s exit spurs new slate of GSK executive changes
How the pharma giant is consolidating power as it looks to become a dominant force in the vaccine market.
By Karissa Waddick • Oct. 31, 2022 -
Opinion
Pharma execs on creating a better workplace culture
Top women execs speak to the leadership skills they are embracing as the industry adjusts to a new normal.
By Taren Grom • Oct. 28, 2022 -
Opinion
What’s keeping pharma leaders up at night
C-suite execs in the life sciences share their late-night thoughts including innovation, patient access and market factors.
By Taren Grom • Oct. 21, 2022 -
J&J reveals just how much economic turbulence is affecting Big Pharma
The healthcare giant showed pharmaceutical gains, but that's no thanks to the economic environment of persistent inflation and a strong U.S. dollar.
By Michael Gibney • Oct. 20, 2022 -
Podcast
Woman of the Week: Exscientia’s Charlotte Deane
Is the industry ready for a biologic discovery revolution? Charlotte Deane, chief scientist of biologics AI at Exscientia, thinks so.
By Taren Grom • Oct. 19, 2022 -
Q&A
He helped discover BMS’s psoriasis pill Sotyktu. Here’s what he has to say about early science in Big Pharma
Bristol Myers Squibb’s senior principal scientist Ryan Moslin shares why his team was built for success and how they ushered a potential psoriasis blockbuster through discovery.
By Michael Gibney • Oct. 17, 2022 -
Making Moves
BIO’s interim CEO and Alvotech’s new chief quality officer could spell big changes for biotech
What these life science organizations’ latest executive-level appointments mean for the industry.
By Karissa Waddick • Oct. 14, 2022 -
Opinion
What’s your leadership brand?
Pharma industry leaders share their brand personas.
By Taren Grom • Oct. 14, 2022 -
Q&A // First 90 Days
Coming out of stealth, RIGImmune aims to catch up with ever-mutating viruses
President Susan Sobolov discusses how the startup is building on the work of two powerhouse Yale scientists to advance candidates for viruses — and beyond.
By Kelly Bilodeau • Oct. 13, 2022 -
Q&A
Where the CEO of ADC Therapeutics sees ‘huge potential’ in the tech beyond oncology
The “magic bullet” approach of ADCs has been a breakthrough in cancer care — but this excitement could be just the beginning.
By Meagan Parrish • Oct. 12, 2022 -
Podcast
Woman of the Week: HBA’s Nikki Jones
As the Healthcare Businesswomen’s Association’s first chief people and DEI officer, Jones is poised to tackle pay gap inequity, systemic gender bias and leadership barriers impeding women of color.
By Taren Grom • Oct. 12, 2022 -
Opinion
Are you a bad boss?
Pharma execs share their tips for being a better leader.
By Taren Grom • Oct. 7, 2022 -
Podcast
Woman of the Week: Janssen’s Fiona Elwood
The neurodegeneration lead at Janssen is driving precision-based medicine to better understand the pathology of neurological disease for the greatest patient impact.
By Taren Grom • Oct. 5, 2022 -
The 2 areas in life sciences most in need of talent
The industry is feeling the hiring crunch — here’s what pharma companies can do to mitigate the impact.
By Meagan Parrish • Oct. 4, 2022 -
Q&A
Keytruda is the gift that keeps on giving for Merck, and here’s what’s next for the cancer juggernaut
Long-term results showed five-year survival numbers for lung cancer patients that surpassed all others, and Merck's VP of oncology research tells us what he's excited about.
By Michael Gibney • Oct. 3, 2022 -
How do Biogen-Eisai’s two Alzheimer’s drugs stack up?
Biogen and Eisai's newest Alzheimer's success begs comparison to their past debacle — and bolsters the amyloid theory.
By Michael Gibney • Sept. 30, 2022 -
Podcast
Woman of the Week: Pepper Bio’s Samantha Dale Strasser
The co-founder of Pepper Bio entered the biotech world three years ago with the goal of transforming drug discovery through the emerging discipline of transomics.
By Taren Grom • Sept. 28, 2022 -
Podcast
Woman of the Week: Agilent Technologies’ Dr. Katharine Knobil
As the first chief medical officer of the diagnostic testing company, Dr. Katharine Knobil is focused on moving the science forward beyond precision oncology to liquid biopsy.
By Taren Grom • Sept. 14, 2022 -
From the ‘go-go days’ to a bubble crunch — the biotech sector faces its next challenge
The highs of the sector in early 2021 gave way to a bear market that persisted into the second half of this year — but there's hope the bubble hasn't popped for good.
By Michael Gibney • Sept. 12, 2022 -
Podcast
Woman of the Week: Foresite Capital’s Cindy Mesaros
The longtime marketing pro details her fascinating career journey and how she’s positioning early stage health companies to thrive.
By Taren Grom • Sept. 7, 2022 -
First 90 Days
First 90 Days: Adaptive Biotech’s Tycho Peterson
A long-time analyst, Tycho Peterson brings his business savvy to the C-suite at Adaptive, where he began as CFO in June with a knowledge of what works and what doesn't in the diagnostics space.
By Michael Gibney • Sept. 1, 2022 -
Podcast
Woman of the Week: Thread’s Kim Boericke
Fresh off an eight-year tour of duty at ICON, the CRO industry veteran is stepping into a new role and a new title as chief delivery officer at Thread.
By Taren Grom • Aug. 31, 2022 -
Profile
Leading the industry’s next potential game-changer in drug discovery
Rachel Meyers, chief scientific officer at Faze Medicines, is helping guide the company towards the development of biomolecular condensates — an emerging field that could transform drug discovery.
By Alexandra Pecci • Aug. 29, 2022